Spots Global Cancer Trial Database for pathological response
Every month we try and update this database with for pathological response cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer | NCT04418089 | Breast Cancer Chemotherapy Ef... | Simvastatin 40m... Placebo oral ca... | - | Indonesia University | |
| Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma | NCT04310397 | Pathologic Stag... Pathologic Stag... Pathologic Stag... | Dabrafenib Spartalizumab Therapeutic Con... Trametinib | 18 Years - | M.D. Anderson Cancer Center | |
| Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer | NCT05600127 | Urothelial Carc... | Avelumab | 18 Years - | Erasmus Medical Center | |
| Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI. | NCT01858649 | Metastatic Colo... | Metastases rese... Bevacizumab 5 FU Oxaliplatin Irinotecan | 18 Years - | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | |
| Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer | NCT04418089 | Breast Cancer Chemotherapy Ef... | Simvastatin 40m... Placebo oral ca... | - | Indonesia University | |
| The Role of Simvastatin in The Epithelial-Mesenchymal Transition Process of Breast Cancer | NCT05550415 | Triple Negative... Chemotherapy Ef... Simvastatin Adv... | Simvastatin 40m... Placebo | 18 Years - | Indonesia University | |
| Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI. | NCT01858649 | Metastatic Colo... | Metastases rese... Bevacizumab 5 FU Oxaliplatin Irinotecan | 18 Years - | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | |
| Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors | NCT01858662 | Metastatic Colo... | Metastases Rese... 5-Fluorouracile leucovorin L Oxaliplatin Irinotecan Cetuximab | 18 Years - | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | |
| A Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma | NCT05418972 | Stage II Melano... | Relatlimab and ... | 18 Years - | Melanoma Institute Australia | |
| Transcatheter Intra-arterial Limb Infusion of Cisplatin for Extremity Osteosarcoma | NCT03909776 | Event-free Surv... Overall Surviva... Local-recurrenc... Pathological Re... | Cisplatin | - | Peking University People's Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
